Biovail Corp: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
760.87 Mil |
| Income |
223.84 Mil |
| Net Profit Margin |
29.42% |
| Return on Equity |
18.23% |
| Debt/Equity Ratio |
0.00 |
|
| Revenue/Share |
4.80 |
| Earnings/Share |
1.41 |
| Book Value/Share |
8.16 |
| Dividend Rate |
0.36 |
| Payout Ratio |
66.00% |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 173.3 | 208.5 | 247.0 |
| 2nd Qtr | 193.5 | 186.1 | 203.0 |
| 3rd Qtr | 212.5 | 181.1 | 188.9 |
| 4th Qtr | NA | 181.5 | 203.9 |
| Total | 579.4 | 757.2 | 842.8 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | $0.25 | $0.35 | $0.58 |
| 2nd Qtr | $0.15 | -$0.16 | $0.42 |
| 3rd Qtr | $0.26 | $0.31 | $0.41 |
| 4th Qtr | NA | $0.76 | -$0.20 |
| Total | $0.66 | $1.26 | $1.21 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -67% | NA | --- |
| 2nd Qtr | -40% | NA | -28% |
| 3rd Qtr | 73% | NA | -2% |
| 4th Qtr | NA | 145% | NA |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | -29% | -40% |
| 2nd Qtr | NA | NA |
| 3rd Qtr | -16% | -24% |
| 4th Qtr | NA | NA |
advertisement
Recent News